ArticleJournal of inflammation research2025
Neutrophils in Rheumatoid Arthritis Synovium: Implications on Disease Activity and Inflammation State.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between neutrophil-to-lymphocyte ratio and the prognosis of patients with rheumatoid arthritis: a meta-analysis.Frontiers in immunology · 2026Pooled it
- [Immune cell populations in rheumatoid arthritis and giant cell arteritis].Zeitschrift fur Rheumatologie · 2026Review
- Synovial microenvironment and fluorescence imaging for early rheumatoid arthritis diagnosis.Journal of pharmaceutical analysis · 2026Review
- Synovial Fluid Characteristics and Pain Recovery Trajectory Following Rehabilitation in Patients with Meniscal Tears: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Cannabigerol (CBG) Modulates Neutrophil Activity and Ameliorates Rheumatoid Arthritis Pathogenesis.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond.International journal of molecular sciences · 2026Review
- Altered neutrophil signalling linked to impaired chemotaxis and increased ROS and NET production in older people with frailty.Clinical and experimental immunology · 2026Article
- Advances in the study of low-density neutrophils in rheumatic diseases.Frontiers in immunology · 2026Review
- Targeting GM-CSF in Rheumatoid Arthritis: Advances in Cytokine-Directed Immunotherapy and Clinical Implications.Life (Basel, Switzerland) · 2025Review
- The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation driven by immune cell infiltration. While neutrophils have traditionally been associated with acute inflammation, emerging evidence suggests their significant role in chronic RA synovitis. Synovial pathology reports from our center reveal lymphocyte-predominant infiltration in most RA cases, with synovial neutrophils (SNs) observed in only 30% of patients. This finding suggests that neutrophil involvement in RA pathogenesis is not universal but subtype-specific, potentially linked to distinct clinical phenotypes. Methods: We performed a retrospective analysis of synovial pathology and clinical data from 55 RA patients collected during 2023. Using both Hematoxylin-Eosin (H&E) staining and single-cell RNA sequencing, we analyzed the synovial tissue samples. Based on neutrophil counts, patients were classified into two groups: neutrophil-absent (<10 neutrophils) and neutrophil-present (≥10 neutrophils). Results: In this cohort of 55 RA patients, the synovial neutrophil (SN) group demonstrated significantly elevated disease activity markers, including Disease Activity Score in 28 joints based on C-reactive protein (DAS28-CRP), swollen joint count (SJC28), Visual Analog Scale (VAS) pain scores, and tender joint count (TJC28) (p < 0.05 for all parameters). Synovial inflammatory infiltration and neovascularization were markedly increased in the SNs group (P < 0.05). Patients with SNs maintained higher disease activity and showed poorer therapeutic responses despite treatment with methotrexate and targeted biologics (TNF inhibitors, IL-6 inhibitors, or JAK inhibitors). Analysis revealed a positive correlation between lymphocyte and neutrophil counts, while multivariate analysis identified DAS28-CRP, synovial inflammation, and CD3+/CD68+ cell counts as predictors of SN infiltration. Single-cell RNA sequencing confirmed their significant presence in synovial tissue, supporting neutrophils' role in refractory disease. Conclusion: Elevated neutrophil presence in RA synovium correlates with heightened clinical disease activity and an exacerbated inflammatory state. These findings underscore the potential significance of SNs in the pathology of RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.